eye
EYE: MIGS Pioneer - Breakeven or Bust in the Canal Zone
Updated 8 Oct 2025
Nova Eye Medical: BUY rating, A$0.48 fair value vs A$0.14 current price (243% upside). Pre-profit MIGS specialist targeting H1FY26 breakeven with 25% revenue growth.
View note